Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 18Neoplasms 11Venous Thrombosis 9Pulmonary Embolism 9Thrombosis 5Multiple Myeloma 4Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Intracranial Thrombosis 2Hematologic Neoplasms 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Upper Extremity Deep Vein Thrombosis 1Thromboprophylaxis 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Mesenteric Ischemia 1Leukemia 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Gastrointestinal Stromal Tumors 1

Interventions

eltrombopag 14romiplostim 7avatrombopag 6Cytarabine 6Platelet Transfusion 5Filgrastim 4Etoposide 4Carboplatin 4oprelvekin 3Tranexamic Acid 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3Cyclophosphamide 3Busulfan 3hetrombopag 2fludarabine phosphate 2Tretinoin 2Thrombopoietin 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Cyclosporine 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1siltuximab 1sargramostim 1raltitrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thrombocytopenia × apixaban × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡